Topical fluoroquinolones: Antimicrobial activity and in vitro corneal epithelial toxicity

References

• Jones D. B. Decision-making in the management of microbial keratitis. Ophthalmology 1981; 88: 814–820
   PubMed Web of Science ®Google Scholar
• Liesegang T. J., Forster R. K. Spectrum of microbial keratitis in South Florida. Am. J. Ophthalmol. 1981; IX: 38–47
   Google Scholar
• Wilson L. A. Acute bacterial infection of the eye: Bacterial keratitis and endophthalmitis. Trans. Ophthalmol. Soc. U.K. 1986; 105: 43–60
   PubMedGoogle Scholar
• Baum J. Therapy for ocular bacterial infection. Trans. Ophthalmol. Soc. U.K. 1986; 105: 69–77
   PubMedGoogle Scholar
• Gelender H., Rettich C. Genta-micin resistant Pseudomonas aeruginosa corneal ulcers. Cornea 1984; 3: 21–26
   PubMedGoogle Scholar
• Lorian V., Atkinson B. Bacterial resistance to antibiotics in the United States. Ten million strains, nine species, and sixteen antibiotics. Drugs Exp. Clin. Res. 1987; 13: 457
   PubMedGoogle Scholar
• Hobden J. A., Reidy J. J., O'Callaghan R. J., Insler M. S., Hill J. M. Quino-lones in collagen shields to treat aminogly-coside-resistant pseudomonal keratitis. Invest. Ophthalmol. Vis. Sci. 1990; 31: 2241–2243
   PubMed Web of Science ®Google Scholar
• Smolin G. R., Okumoto M., Wilson F. M. The effect of tobramycin on gentami-cin-resistant strains in Pseudomonas keratitis. Am. J. Ophthalmol. 1974; 77: 583–588
   PubMed Web of Science ®Google Scholar
• Laibson P., Michaud R., Smolin G., Okumoto M., Rosenthal A., Cagle G. A clinical comparison of tobramycin and genta-micin sulfate in the treatment of ocular infections. Am. J. Ophthalmol. 1981; 62: 836–841
   Google Scholar
• Leibowitz H. M., Hyndiuk R. A., Smolin F. R., Nozik R. A., Hunter G. J., Cagle G. D., Davis D. S. Tobramycin in external eye disease: A double-masked study vs. genta-micin. Curr. Eye Res. 1981; j: 259–266
   Google Scholar
• Wilson L. A., Weinstein A. J., Wood T. O., Lindsey C., Davis D. S. Treatment of external eye infections: A double-masked trial of tobramycin and gentamicin. J. Ocular Ther. Surg. 1982; 364–367
   Google Scholar
• Cagle G., Davis S., Rosenthal A., Smith J. Topical tobramycin and gentami-cin sulfate in the treatment of ocular infections: Multicenter study. Curr. Eye Res. J. 1982; 523–534
   Google Scholar
• Wilhelmus K. R., Gilbert M. L., Osato M. S. Tobramycin in ophthalmology. Surv. Ophthalmol. 1987; 32: 111–122
   PubMed Web of Science ®Google Scholar
• Lass J. H., Mack R. J., Imperia P. S., Mal-lick K., Lazarus H. M. An in vitro analysis of aminoglycoside corneal epithelial toxicity. Curr. Eye Res. 1989; 8: 299–304
   PubMed Web of Science ®Google Scholar
• Samples J. R., Baumgartner S. D., Binder P. S. Infectious crystalline keratopathy: An electron microscope analysis. Cornea 1985–1986; U: 118–126
   Google Scholar
• Meisler D. M., Langston R. H.S., Naab T. J., Aaby A. A., KcMahon J. R., Tubbs R. R. Infectious crystalline keratopathy. Am. J. Ophthalmol. 1984; 97: 337–343
   PubMed Web of Science ®Google Scholar
• Walker R. C., Wright A. J. The quinolones. Mayo Clin. Proc. 1987; bl: 1007–1012
   Google Scholar
• Shungu D. L., Tutlane V. K., Weinberg E., Gadebusch H. H. In vitro antibacterial activity of norfloxacin and other agents against ocular pathogens. Chemotherapy 1985; 31: 112–118
   PubMed Web of Science ®Google Scholar
• Goldstein E. J.G., Citron D. M., Bendon L., Wagvolgxi A. E., Trousdale M. D., Appleman M. D. Potential of topical norfloxacin therapy. Comparative jLn_ vitro activity against clinical ocular bacterial isolates. Arch. Ophthalmol. 1987; 105: 991–994
   Google Scholar
• Osato M. S., Jensen H. G., Trousdale M. D., Bosso J. A., Borrmann L. R., Frank J., Akers P. The comparative in vitro activity of ofloxacin and selected ophthalmic antimicrobial agents against ocular bacterial isolates. Am. J. Ophthalmol. 1989; 108: 380–386
   PubMed Web of Science ®Google Scholar
• Barry A. L., Jones R. N. In vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents. J. Antimicrob. Chemother. 1989; 23: 527–535
   PubMed Web of Science ®Google Scholar
• Nye K., Shi Y. G., Andrews J. M., Ashby J. P., Wise R. The in vitro activity, pharmacokinetics and tissue penetration of temafloxacin. J. Antimicrob. Chemother. 1989; 24: 415–424
   PubMed Web of Science ®Google Scholar
• Richman J., Zolezio H., Tang-Liu D. Comparison of ofloxacin, gentamicin, and tobramycin concentrations in tears and in vitro HICs for 90% of test organisms. Antimicrob. Agents Chemother. 1990; 4: 1602–1604
   Google Scholar
• Imperia P. S., Lazarus H. M., Botti R. E., Lass J. H. An in vitro method for measuring ophthalmic preservative cytotoxicity. J. Toxicol.–Cut. & Ocular Toxicol. 1986; 5: 309–317
   Web of Science ®Google Scholar
• Botti R. E., Lazarus H. M., Imperia P. S., Lass J. H. Cytotoxicity of antineoplastic agents on rabbit corneal epithelium in vitro. J. Toxicol.–Cut. & Ocular Toxicol. 1987; 11: 79–87
   Google Scholar
• Imperia P. S., Lazarus H. M., Dunkel E. C., Pavan-Langston D., Geary P. A., Lass J. H. An in vitro study of ophthalmic anti-viral agent toxicity on rabbit corneal epithelium. Antiviral Res. 1988; 9: 263–272
   PubMed Web of Science ®Google Scholar
• Cutarelli P. E., Mackr J., Lazarus H. M., Jacobs M. R., Lass J. H. An in vitro analysis of cephalosporin corneal-epithelial toxicity. J. Toxicol.–Cut. & Ocular Toxicol. 1990; 1: 99–107
   Google Scholar
• The National Committee for Clinical Laboratory Standards. Tentative Standard M7-T2. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobi-cally. Villanova, PA 1988
   Google Scholar
• Gipson I. K., Grill S. M. A technique for obtaining sheets of intact rabbit corneal epithelium. Invest. Ophthalmol. Vis. Sci. 1982; 23: 269–273
   PubMed Web of Science ®Google Scholar
• Jumblatt M. M., Neufeld A. H. 6-adrenergic and serotonergic responsiveness of rabbit corneal epithelial cells in culture. 1983
   Google Scholar
• Jacobsen J. A., Call N. B., Kasworm E. M., Dirks M. S., Turner R. B. Safety and efficacy of topical norfloxacin versus tobramycin in the treatment of external ocular infections. Antimicrob. Agents & Chemother. 1988; 132: 1820–1824
   Google Scholar
• Wilhelmus K. R., O'Brien T. P., Osato M. S., Abshire R. L., Folkens A. T. Clinical efficacy of ciprofloxacin for bacterial keratitis. Invest. Ophthalmol. Vis. Sci. 1990; 31: 556, suppl)
   Google Scholar
• Havener W. H. Wetting agents. “Ocular Pharmacology”, W. H. Havener. C.V. Mosby, St Louis 1983; 622–634
   Google Scholar
• Martin B. M., Gimbrone M. A., Jr., Unanue E. R., Cotran R. S. Stimulation of non-lymphoid mesenchymal cell proliferation by a macrophage-derived growth factor. J. Immunol. 1981; 126: 1510–1515
   PubMed Web of Science ®Google Scholar
• O'Brien T. P., Sawusch M. R., Dick J. D., Gottsch J. D. Topical ciprofloxacin treatment of Pseudomonas keratitis in rabbits. Arch. Ophthalmol. 1988; 106: 1444–1446
   PubMed Web of Science ®Google Scholar
• Reidy J. J., Hobden J. A., Hill J. M., Forman K., O'Callaghan R. J. The efficacy of topical ciprofloxacin and norfloxacin in the treatment of experimental Pseudomonas keratitis. Cornea 1991; 10: 25–28
   PubMed Web of Science ®Google Scholar
• Galbis C. G., Soriano F. M., Herrero I. R. Ofloxacin and corneal epithelial wound healing. Invest. Ophthalmol. Vis. Sci. 1990; 31: 315, suppl)
   Web of Science ®Google Scholar
• Nelson J. D., Silverman V., Lima P. H., Bechman G. Corneal epithelial wound healing: a tissue culture assay on the effect of antibiotics. Curr. Eye Res. 1990; 9: 277–285
   PubMed Web of Science ®Google Scholar
• Borrmann L. R., Leopold I. H. The potential use of quinolones in future ocular antimicrobial therapy. Am. J. Ophthalmol. 1988; 106: 227–228
   PubMed Web of Science ®Google Scholar